Resultados da pesquisa - (( j el omer cihan newts ) OR ((( m nac56 complex cell now ) OR ( a good company care non ))))

1

The effects of Hedera helix on viral respiratory infections in humans: A rapid review

The effects of Hedera helix on viral respiratory infections in humans: A rapid review

Por Barnes, Larisa AJ, Leach, Matthew, Anheyer, Dennis, Brown, Danielle, Carè, Jenny, Lauche, Romy, Medina, Daen N, Pinder, Tobey-Ann, Bugarcic, Andrea, Steel, Amie
Publicado no Adv Integr Med (2020)

“... and herbal complex preparations including H. helix may be a therapeutic option for treating early symptoms...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method

Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method

Por Neilson, Lynn M., Swart, Elizabeth C. S., Good, Chester B., Shrank, William H., Henderson, Rochelle, Manolis, Chronis, Parekh, Natasha
Publicado no Cardiol Ther (2019)

“...), and pharmaceutical company representatives (n = 2). A list of 16 CAD-associated clinical indicators was generated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

In Good Company? Perception of Movement Synchrony of a Non-Anthropomorphic Robot

In Good Company? Perception of Movement Synchrony of a Non-Anthropomorphic Robot

Por Lehmann, Hagen, Saez-Pons, Joan, Syrdal, Dag Sverre, Dautenhahn, Kerstin
Publicado no PLoS One (2015)

“... was Care-O-bot3, a non-anthropomorphic robot with a limited range of expressive motions. We found that even...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety

Por Naughton, Bernard D, Smith, James A, Brindley, David A
Publicado no Eur J Hosp Pharm (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

“A Good Habit”: Telehealth PrEP Users Find Benefit in Quarterly Monitoring Requirements

“A Good Habit”: Telehealth PrEP Users Find Benefit in Quarterly Monitoring Requirements

Por Koester, Kimberly A., Hughes, Shana D., Grant, Robert M.
Publicado no J Int Assoc Provid AIDS Care (2020)

“... visits or completing laboratory testing. To study PrEP services offered by a telehealth company called...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis

Por Axson, Sydney A, Mello, Michelle M, Lincow, Deborah, Yang, Catherine, Gross, Cary P, Ross, Joseph S, Miller, Jennifer
Publicado no BMJ Open (2021)

“...OBJECTIVES: To examine company characteristics associated with better transparency and to apply a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

The well-being valuation model: a method for monetizing the nonmarket good of individual well-being

The well-being valuation model: a method for monetizing the nonmarket good of individual well-being

Por Sidney, James A., Jones, Ashlin, Coberley, Carter, Pope, James E., Wells, Aaron
Publicado no Health Serv Outcomes Res Methodol (2016)

“... improvement programs, offered by population health management companies, by presenting a novel method...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

How do we deal with multiple goals for care within an individual patient trajectory? A document content analysis of health service research papers on goals for care

How do we deal with multiple goals for care within an individual patient trajectory? A document...

Por Berntsen, G K R, Gammon, D, Steinsbekk, A, Salamonsen, A, Foss, N, Ruland, C, Fønnebø, V
Publicado no BMJ Open (2015)

“...OBJECTIVES: Patients with complex long-term needs experience multiple parallel care processes...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

Por Mazhar, Faizan, Hadi, Muhammad Abdul, Kow, Chia Siang, Marran, Albaraa Mohammed N., Merchant, Hamid A., Hasan, Syed Shahzad
Publicado no Int J Infect Dis (2020)

“... September 2020. The Cochrane risk-of-bias tools for randomized trials and non-randomized trials...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Good-quality social care for people with Parkinson’s disease: a qualitative study

Good-quality social care for people with Parkinson’s disease: a qualitative study

Por Tod, Angela Mary, Kennedy, Fiona, Stocks, Amanda-Jayne, McDonnell, Ann, Ramaswamy, Bhanu, Wood, Brendan, Whitfield, Malcolm
Publicado no BMJ Open (2016)

“... with a former commissioner. FINDINGS: Good-quality social care, delivered in a timely fashion...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms

Por Mowat, Craig, Digby, Jayne, Strachan, Judith A, Wilson, Robyn, Carey, Francis A, Fraser, Callum G, Steele, Robert J C
Publicado no Gut (2016)

“... adenoma and no additional cancers. CONCLUSIONS: In primary care, undetectable FHb is a good ‘rule-out...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy...

Por Peters, Esther, Mehta, Ravindra L, Murray, Patrick T, Hummel, Jürgen, Joannidis, Michael, Kellum, John A, Arend, Jacques, Pickkers, Peter
Publicado no BMJ Open (2016)

Assuntos: “...Intensive Care...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

COVID-19 survey burden for health care workers: literature review and audit

COVID-19 survey burden for health care workers: literature review and audit

Por Gnanapragasam, S.N., Hodson, A., Smith, L.E., Greenberg, N., Rubin, G.J., Wessely, S.
Publicado no Public Health (2022)

“... Medical Association), and the YouGov website. For the audit, a non-random purposive sample of six HCWs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study

Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A...

Por van Oers, Jos A.H., Kluiters, Yvette, Bons, Judith A.P., de Jongh, Mariska, Pouwels, Sjaak, Ramnarain, Dharmanand, de Lange, Dylan W., de Grooth, Harm-Jan, Girbes, Armand R.J.
Publicado no J Crit Care (2021)

“... biomarkers and mortality in a multivariable Cox regression model adjusted for age and SOFA score. RESULTS...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

Por Pasomsub, E., Watcharananan, S.P., Boonyawat, K., Janchompoo, P., Wongtabtim, G., Suksuwan, W., Sungkanuparph, S., Phuphuakrat, A.
Publicado no Clin Microbiol Infect (2021)

“..., there is a need for a quick and easy method to obtain a non-invasive sample for the detection of this novel...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Modelo de evaluación del plan de respuesta frente a la pandemia de COVID-19 en un hospital de tercer nivel

Modelo de evaluación del plan de respuesta frente a la pandemia de COVID-19 en un hospital de tercer nivel

Por Llorente-Parrado, C., Mejon-Berges, R., Cossio-Gil, Y., Romea-Lecumberri, M.S., Roman-Broto, A., Barba-Flores, M.A., Salazar-Soler, A.
Publicado no J Healthc Qual Res (2020)

“..., with 42 areas for improvement and 96 good practices identified. CONCLUSIONS: Implementing a standards...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Chimeric antigen receptor T cell therapy comes to clinical practice

Chimeric antigen receptor T cell therapy comes to clinical practice

Por Wall, D.A., Krueger, J.
Publicado no Curr Oncol (2020)

“...—responses that were so impressive that a shift in the paradigm of care has now occurred for children...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials

It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials

Por Ravinetto, Raffaella, Tinto, Halidou, Diro, Ermias, Okebe, Joseph, Mahendradhata, Yodi, Rijal, Suman, Gotuzzo, Eduardo, Lutumba, Pascal, Nahum, Alain, De Nys, Katelijne, Casteels, Minne, Boelaert, Marleen
Publicado no BMJ Glob Health (2016)

“... field experience in LMICs, we developed a non-exhaustive set of recommendations for the improvement...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Five-year clinical outcomes with endoscopic transforaminal outside-in foraminoplasty techniques for symptomatic degenerative conditions of the lumbar spine

Five-year clinical outcomes with endoscopic transforaminal outside-in foraminoplasty techniques for symptomatic degenerative conditions of the lumbar spine

Por Lewandrowski, Kai-Uwe, Ransom, Nicholas A.
Publicado no J Spine Surg (2020)

“..., and unintended after care with the outside-in endoscopic transforaminal foraminoplasty for symptoms from lumbar...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Guidelines, Editors, Pharma And The Biological Paradigm Shift

Guidelines, Editors, Pharma And The Biological Paradigm Shift

Por Singh, Ajai R., Singh, Shakuntala A.
Publicado em 2007

“... in India to limit pharma company expenses over junkets and trinkets is a welcome step. Clinical practice...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[13]